A feasibility study of a SDM intervention for the decision making process in advanced Parkinson’s disease
- Conditions
- <p>Advanced Parkinson's disease<br />Parkinson</p>10028037
- Registration Number
- NL-OMON21200
- Lead Sponsor
- Radboud Institute for Health Sciences, Department of Neurology
- Brief Summary
not applicable
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Five hospitals will participate and are selected from our previous studies. Specialised neurology centers and community based hospitals will be represented, because they have differential access to advanced PD treatments. Neurologists in these hospitals will be eligible if they (1) consider at least five PD patients per year for advanced treatment; and (2) collaborate with a PD nurse specialist in the same hospital. We aim for a total of five to ten neurologists, each participating centre may provide more than one neurologist. Moreover, we aim to include professionals with different levels of expertise on the advanced treatment options. Patients may be included if they: 1) are diagnosed with advanced PD and are considered for advanced treatment, judged by their own neurologist; and 2) are eligible for all three treatments at the beginning of the decision-making process.
Exclusion criteria for patients are: Current or previous advanced treatment for Parkinson's Disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>This feasibility study will focus on four aspects, being acceptability, level of implementation, small-scale efficacy testing, and evaluation of study procedures, each with their own relevant outcome measures (see secondary outcomes for more detail)<br /><br><br /><br>In order to increase cross-validation of the data contextual factors will also be measured.</p><br>
- Secondary Outcome Measures
Name Time Method